Journal Article

Unproven Stem Cell Industry in the U.S.: Regulatory Challenges and Enforcement Issues

Biotechnology Law Report (2023) 42(4) 184-198
DOI: 10.1089/blr.2023.29315.pf
3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Author supplied keywords

Cite

CITATION STYLE

APA

Foong, P. (2023). Unproven Stem Cell Industry in the U.S.: Regulatory Challenges and Enforcement Issues. Biotechnology Law Report, 42(4), 184–198. https://doi.org/10.1089/blr.2023.29315.pf

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free